Tags

Type your tag names separated by a space and hit enter

Cannabinoids: for better and for worse .
Dialogues Clin Neurosci. 2020 09; 22(3):201-204.DC

Abstract

The use of cannabis as a drug has undergone a remarkable change of direction: considered as a symbol of countercultures in past decades, it is presently being hailed as a cure for any number of diseases and conditions. Thus, despite concerns about the safety of cannabis and cannabinoids, quite a few drugs that contain cannabinoids have recently been approved by several drug agencies, and the medicinal and recreational use of cannabis has been legalized in various countries and states. The promise of cannabinoids for therapeutic use, as well as potentially detrimental health risks and regulatory issues, will need to be carefully weighed. .

Authors+Show Affiliations

University Hospital Cochin, site Tarnier, Paris, France; Faculty of Medicine Paris Descartes (University of Paris); INSERM U1266, Institute of Psychiatry and Neuroscience, Paris, France, ORCID : 0000-0002-0204-5435.Department of Computational Molecular Biology, Max Planck Institute for Molecular Genetics, Berlin, Germany.

Pub Type(s)

Editorial

Language

eng

PubMed ID

33162763

Citation

Thibaut, Florence, and Margret R. Hoehe. "Cannabinoids: for Better and for Worse ." Dialogues in Clinical Neuroscience, vol. 22, no. 3, 2020, pp. 201-204.
Thibaut F, Hoehe MR. Cannabinoids: for better and for worse . Dialogues Clin Neurosci. 2020;22(3):201-204.
Thibaut, F., & Hoehe, M. R. (2020). Cannabinoids: for better and for worse . Dialogues in Clinical Neuroscience, 22(3), 201-204. https://doi.org/10.31887/DCNS.2020.22.3/fthibaut
Thibaut F, Hoehe MR. Cannabinoids: for Better and for Worse. Dialogues Clin Neurosci. 2020;22(3):201-204. PubMed PMID: 33162763.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Cannabinoids: for better and for worse . AU - Thibaut,Florence, AU - Hoehe,Margret R, PY - 2020/11/9/entrez PY - 2020/11/10/pubmed PY - 2021/10/12/medline KW - cannabidiol KW - cannabinoid KW - cannabis use disorder (CBD) KW - drug safety KW - endocannabinoid signaling KW - endocannabinoid system KW - fatty acid amide hydrolase KW - health risk KW - legalization KW - mental disease KW - psychosis KW - regulation KW - tetrahydrocannabinol (THC) SP - 201 EP - 204 JF - Dialogues in clinical neuroscience JO - Dialogues Clin Neurosci VL - 22 IS - 3 N2 - The use of cannabis as a drug has undergone a remarkable change of direction: considered as a symbol of countercultures in past decades, it is presently being hailed as a cure for any number of diseases and conditions. Thus, despite concerns about the safety of cannabis and cannabinoids, quite a few drugs that contain cannabinoids have recently been approved by several drug agencies, and the medicinal and recreational use of cannabis has been legalized in various countries and states. The promise of cannabinoids for therapeutic use, as well as potentially detrimental health risks and regulatory issues, will need to be carefully weighed. . SN - 1958-5969 UR - https://www.unboundmedicine.com/medline/citation/33162763/Cannabinoids:_for_better_and_for_worse__ L2 - https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33162763/ DB - PRIME DP - Unbound Medicine ER -